Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Circulation. 2021 Jan 27;143(7):661–672. doi: 10.1161/CIRCULATIONAHA.120.051558

Table 4.

CABANA primary and secondary outcomes compared by sex stratified by randomized treatment strategies

Event Group aHR* (95% CI)
Primary Composite Outcome
Primary composite outcome Ablation 0.95 (0.60, 1.52)
Drug 0.69 (0.43, 1.11)
Primary Outcome Components
Death Ablation 0.67 (0.37, 1.22)
Drug 0.99 (0.56, 1.73)
Disabling Stroke Ablation 3.44 (0.27, 43.85)
Drug 0.74 (0.12, 4.71)
Serious Bleeding Ablation 1.10 (0.53, 2.28)
Drug 0.39 (0.17, 0.91)
Cardiac Arrest Ablation 4.86 (0.92, 25.66)
Drug 0.44 (0.05, 3.93)
AF recurrence Ablation 1.19 (0.93, 1.53)
Drug 0.89 (0.70, 1.13)
Secondary Outcomes
Death or CV hospitalization Ablation 1.03 (0.85, 1.24)
Drug 0.95 (0.79, 1.13)
*

aHR: adjusted hazard ratio with male group as a reference.